cell lines can support pluripotent stem cells. For example, we demonstrated' that the stromal cell line S 17" maintained, for at least 3 weeks, stem cells that were quantitatively and qualitatively similar to freshly explanted marrow stem cells. In contrast, three other stromal cell lines failed to retain repopulating stem cells.' This suggested that stromal cells that support stem cells are infrequent in the microenvironment. However, the stromal cell lines used in the previous study were derived from different tissues and different genetic backgrounds. To critically analyze potential heterogeneity within the hematopoietic microenvironment, we isolated a panel of developmentally matched stromal cell lines from fetal liver. We report here that these matched stromal cell lines differ markedly in their ability to support pluripotent stem cells. Our data support the hypothesis that stromal cell lines in vitro can recreate the in vivo microenvironmental niches that selectively regulate stem cell proliferation and differentiation.
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MATERIALS AND METHODS
Timed-pregnant mice were purchased from Jackson Laboratories (Bar Harbor, ME). On day 14 of gestation, fetal livers were dissected from fetuses and were disassociated by gentle pipetting. Cells were suspended in a modified Dexter medium containing 12.5% horse serum, 12.5% fetal calf serum (both from HyClone, Logan, UT), 5 x lo-' m o m P-mecaptoethanol (ME), lo-' m o m hydrocortisone (Sigma, St Louis, MO) in IMDM. Tissue culture dishes (10 cm) containing 4 X lo7 cells were maintained at 37"C, 5% C02, 100% humidity. After adherent cells became 50% confluent, cultures were immortalized by introduction of a retroviral vector encoding a temperature sensitive SV40 T antigen and also a gene that confers G418 resistance.'6 For this, cells were incubated with filtered (0.45 p) viral supernatants and 2 &mL polybrene for 6 hours. The media was then replaced with modified Dexter media, and the cultures were further incubated for 3 days at 32°C. The cells were then placed under selection in modified Dexter media containing 500 pg/mL G418 (BRUGIBCO, Grand Island, NY).
After 2 to 3 weeks of selection, individual clones of adherent cells were isolated by cloning rings and expanded. These stromal cell lines were maintained by weekly passage in RPMI, supplemented with 5% fetal calf serum and 5 X lo5 m o m ME at 32°C.
These cultures were performed exactly as described.' Briefly, stromal cell lines were grown at 37°C in RPMI, supplemented with 5% fetal calf serum, until confluent. Cultures were then switched to Dexter conditions by completely replacing Isolation of stromal cell lines.
Stem cell cultures.

INFREQUENT STROMAL CELL LINES MAINTAIN STEM CELLS
4083
medium with standard Dexter medium, consisting of IMDM supplemented with 20% horse serum, 5 X lo-' m o m ME, m o m hydrocortisone (Sigma). Cultures were then seeded with 1.5 X lo6 marrow cells derived from C57BL-Ly5.1 mice. All cultures were initiated in duplicate, and each experiment included cultures supported by the stromal cell line SI7 as a control. Cultures were maintained at 37°C and fed weekly with standard Dexter medium. Cultures were harvested after 3 weeks with a brief trypsin treatment as described? Cell counts were performed on cultured cells stained in parallel with Turk's solution and trypan blue; stromal cells were excluded from counts by morphology.
We used the competitive repopulation assay to measure stem cells in stromal cell line-supported cultures as des~ribed.'~'~'~*'' Briefly, irradiated C57BL16 mice (1,062 rads in two doses separated by 2 hours) were injected with an equal dose of cultured test cells and freshly explanted competitor cells. We injected one tenth of a culture, (corresponding to 1.5 X le cells originally seeded) and 1.5 X lo5 freshly explanted host type marrow, unless indicated differently. Injecting a fraction of the cultures permitted a direct comparison of stem cell input with stem cell output after culture and made the assessment of stem cell levels independent of the expansion of mature cells. Groups of five to six mice were injected for each stem cell culture. Reconstituted mice were bled every second month and white blood cells were purified as de~ribed.8'~ The percent repopulation by donor type T and B lymphocytes and myeloid cells was measured by immunofluorescence using monoclonal antibody (MoAb) A-20 specific for the donor type Ly5.1 allele in combination with MoAb specific for Thy-1, B220, Gr-1, and Mac-1 as de~cribed.'.'~ The hybridoma cell line, secreting MoAb A-20, was the generous gift of Dr S. Kimuro (Sloan-Kettering Cancer Center, New York, NY).
Repopulating units (CRU) in groups of mice at different time points were calculated as de~cribed'.'~ according to the following formula: CRU = % donor type cells/(l -% donor type cells) X number of competitor cells. The assay is linear over a wide range of concentrations and highly repr~ducible'~.'' and therefore ideally suited to quantitate stem cells. Furthermore, the assay provides a measurement of the strength of the test stem cells, because they have to compete with freshly explanted stem cells.
The stromal cell line S17 was grown to confluence in 6-well plates. Marrow cells (7.5 x 10' per well) were then either seeded directly onto the stroma or into collagen coated transwells (Costar, Cambridge, MA), and suspended 1 mm above the stroma. Cultures were maintained for 3 weeks and harvested as described above. Cytokine production by the stromal cell lines was evaluated by reverse transcription polymerase chain reaction (RT-PCR)." Total RNA from individual stromal cell lines was isolated by guanidium isothiocyanate and cesium chloride centrifugation. Following DNAse treatment, RNA was isolated after binding to oligo-dT cellulose (type 3) (Collaborative Research, Lexington, MA) and reverse transcribed with random hexamers and Superscript reverse transcriptase according to manufacturer directions ( B W GIBCO). Samples of cDNA corresponding to three ng poly(A) RNA were used in each PCR reaction. Primers for c-kit ligand, IL-6, IL-7, GM-CSF, LIF, TGF-P1, and P-actin were purchased from Stratagene (La Jolla, CA). IGF-1 primers were previously described." The remaining primers were designed from published sequences and included: flk-2 ligand?' MPL-ligat~d,'~ MIP-la," IL-11 ?5 and G-CSF. 26 All primers span at least one introdexon boundary and yield amplification products of a different size with genomic DNA. Table 1 Indianapolis, IN), 1 pmoVL of each primer, and 0.05 ng cDNA. Samples were denatured at 94°C for 2 minutes, followed by amplification rounds consisting of 94°C for 30 seconds (denaturing); 60 to 65°C for 30 seconds (annealing), and 72°C for 60 seconds (extension). Products were visualized by ethidium bromide staining in 1.5% agarose gels. For the detection of cytokine "As in stromal cells 30 cycles provided the best signal, while the control RT-PCR with actin was optimal at 20 cycles.
Welch and Student tests were performed with InStat software (Graphpad, San Diego, CA). derived from these lines (data not shown). The isolation of these lines and their initial screening for the ability to support cobble stone forming area proliferation is described elsewhere (I. Lemischka et al, manuscript in preparation).
Statistical analysis.
RESULTS
Isolation
Stromal cell lines are heterogeneous in supporting stem cells. While it has been hyp~thesized~'.~~ that stem cells are regulated by functionally distinct stromal cells, experimental support for this has not been published so far. The panel of matched lines that we isolated were ideally suited to test that hypothesis. We designed a simple system to screen these lines for their ability to support in vitro stem cells with in vivo repopulation capacity. Confluent cultures of individual stromal cell lines were seeded with marrow cells derived from C57BL-Ly5.1 mice. Following 3 weeks of culture in Dexter conditions, all cells were harvested and stem cell levels in these cultures were measured in the competitive repopulation as~ay.~.~.".'' Previously, we showed that coinjection of a stromal cell line does not affect the outcome of in vivo repopulation assays.8 Cultured cells were injected together with an equal dose of freshly explanted marrow to serve as competitor stem cells (see Materials and Methods). C57BW6 mice (Ly5.2) served as hosts and as a source for competitor marrow cells. Mice were bled in regular intervals and the proportion of donor type repopulation in the B and T lymphocyte and the myeloid lineages derived from the cultured cells (Ly5.1) were measured by immunofluores~e n c e " '~ (Fig I, compare Table 2 ). Thus, we could follow the kinetics of repopulation in individual mice over 7 months posttransplantation. Competitive repopulation units (CRU) in groups of mice were calculated on the basis of the mean percentage of donor type cells in blood at the times indicated (see Materials and Methods). Each experiment included, as a control, stem cells supported by the stromal cell line S17, which as we showed previously: efficiently maintains stem cells that qualitatively and quantitatively resemble marrow resident stem cells. An example of the CRU levels and the kinetics of repopulation in groups of mice injected with cells cultured on different stromal cell lines is depicted in Fig 1 . This figure also summarizes the level of repopulating stem cells maintained on the line SI7 in four independent experiments, each involving groups of five to six mice injected with cells cultured on the line S 17. The low level of variation seen in this series of experiments indicates that this system is quite stable and reliably reflects stem cell support by stromal cell lines. To facilitate comparison between different experiments, data were converted to "percent CRU," where the CRU level maintained on the line S 17 served as standard and was set as 100% (Fig 2) . Thus, stem cell levels sustained by different stromal cell lines were assessed by two criteria: 1) comparison to stem cell levels maintained on the line SI7 and 2) comparison of repopulation capacity of cultured and freshly explanted stem cells within an individual host.
Our analysis revealed extensive functional heterogeneity among the matched stromal cell lines (Figs 1 and 2) . First, 8 of 16 lines tested retained none or very low levels of stem cells that could be detected in the competitive repopulation assay. Examples of these lines are CFC004, 2058, and AFC027. Second, 6 lines in this panel, exemplified by the lines 2018, AFC003, and CFT012, equaled primary stroma,'.' in that stem cells cultured on these lines yielded low levels of donor type cells. Similar to cultures supported by primary stroma, stem cells cultured on most of the lines in this category showed limited persistence in vivo, as evidenced by the declining donor type contribution. This decaying pattern of repopulation is most noticeable in mice that received stem cells cultured on the line 2018 (Fig 2) . Data from individual animals that received cells cultured on the lines 2018, CFCO34, and 2012, respectively, are listed here to demonstrate the extent of repopulation in the lymphoid and myeloid lineages at 7 months postinjection. Four mice per group were randomly chosen from the experiment depicted in Fig 2. Blood samples from individual mice were divided into three aliquots for lineage staining. Data shown are the mean ( t S D ) from these three samples and show the percent of all peripheral white blood cells that expressed the donor-type Ly5.1 antigen. T represents the T lymphocytes. B the B lymphocytes, and M the myeloid cells that express both the donor type Ly5.1 and the corresponding lineage markers. The variability seen in individual mice of a group is typical for long-term repopulation assays because variability is inversely dependent on the number of donor type stem cells injected."
However, even late after transplantation, cells cultured on the line 2018 contributed to T and B lymphocyte and myeloid lineage repopulation ( Table 2 ), suggesting that repopulation was due to pluripotent stem cells albeit with limited repopulation capacity. The decaying contribution of stem cells supported by the stromal cell line 201 8 was verified in an independent experiment and we found 0.2 and 0.1 CRU at 3 and 9 months postinjection, respectively. Third, in this series of experiments we identified two lines, CFCO34 and 2012, that maintained stem cells as well as or better than the line SI7 (Fig 2) . Cells cultured on these lines competed efficiently with freshly explanted marrow and stably repopulated lymphoid and myeloid cells (Table 2 ). Thus, lines that maintained primitive stem cells with extensive repopulation capacity were rare in this panel of lines.
It is well established that stromal cell lines can change during prolonged
When we noted variation in function, morphology, and/or growth kinetics of the lines CFCO34 and 2012, we derived subclones in limiting dilution. A subclone of the line CFCO34, named CFCO34-2, was isolated that closely resembled the parental line in supporting stem cells (Fig 3) . Figure 3 marrow at similar levels as cells cultured on the line SI7 (Fig 3B) . Similarly, cells cultured on the line CFCO34-2 retained the same number of repopulation units found in freshly explanted marrow (Fig 3A) . Stem cell levels derived from cultures supported by the line CFC034-2 (P = .95) or by the line SI7 (P = .86) were not significantly different from those found in freshly explanted marrow. However, subclones that correspond exactly to the parental line 2012 were not found. Figure 4 depicts the level of donor type cells in individual mice injected with cells cultured on the lines 2012-S2, 2012-S4, and 2012-BI. All 2012-subclones tested so far, support only low levels of stem cells (Fig 4) . since about half of the mice showed no donor type repopulation. However, in most of those mice that (by chance) received stem cells, repopulation levels were high and persisted for at least 7 months. The subclones 2012-BI and 2012-S4, like the parental line 2012, supported predominantly very primitive stem cells that showed a delayed onset of repopulation. Thus, the ability to selectively maintain late repopulating, primitive stem cells was comparable in the parental line and in these subclones. Taken together, these results indicate that different types of stromal cells interact selectively with stem cells that differ in primitiveness. Stem cell maintenance is not correlated with expansion qf hematopoietic cells. All stromal cell lines tested were capable of supporting myelopoiesis in Dexter conditions, although the level of myeloid cells recovered after 3 weeks of culture varied among different lines (Fig 5) . However. the ability to expand mature cells and the capacity to support stem cells is not correlated (r = 0.32, P = .16). This indicates that the failure to support stem cells is not due to broadly inhibitory or "toxic" factors. Furthermore, these data support the interpretation that stem cell maintenance is controlled by different mechanisms than maturation and expansion of their progeny.
Lack qf a role for stromal cells in the inoculum for stem cell mcrintenance. Because we seeded the cultures with bone marrow cells, the inoculum itself contained stromal cells. To test whether these stromal elements play a role in stem cell maintenance, we devised two approaches. First. 1.5 X IO6 bone marrow cells were cultured in the absence of any stromal cell lines. Not surprisingly, we found that few, if any, repopulating stem cells were retained after 3 weeks of culture in this condition. Cultures without stromal cell lines contained 0.01 CRU at 2 months postinjection, representing less than 1% of the stem cells originally seeded (1.18 CRU at 2 months in the same experiment). Second, we initiated cultures in transwells, suspended over confluent cultures of the stromal cell line S17. In this system, vigorous hematopoiesis developed in the transwells and stromal cells in the inoculum were confluent within 1 week (data not shown). However, these cultures retained few repopulating Cyrokine ana!\vis. Stromal cell lines are the source of a variety of cytokines that affect immature cells.'." '' Previously, some of the functional heterogeneity of stromal cell lines in supporting different hematopoietic cell types has been traced back to the production of different cytoSince our stromal cell lines differed in stem cell support, it could be expected that they would produce different cytokines and regulatory molecules. We used RT-PCR to assess transcription of the cytokines TGF-P, MIPla, IGF-I, LIF, G-CSF, GM-CSF, IL-6, IL-7, IL-l I , c-kit ligand, flk-2 ligand, and MPL ligand ( Table 3) . Surprisingly. the stromal cell lines within the panel derived from the fetal liver varied little in cytokine production, at least on the RNA level. All stromal cell lines tested produced readily detectable levels of c-kit ligand and flk-2 ligand. Moreover, there was no obvious correlation of the patterns of cytokine transcription and stem cell support. kine, . . I .? I .? I .??. 34 
DISCUSSION
We report here the first comprehensive analysis of how well-matched stromal cell lines support repopulating stem cells. The level of stem cells retained in culture was not correlated either with the ability of these lines to expand mature cells nor with the pattern of transcription of a large panel of cytokines. This suggests that yet to be characterized interactions mediate stromal cell-controlled stem cell maintenance.
The studies presented here were designed to assess heterogeneity within the stroma compartment. The establishment of primary stromal cell lines is a rare event, and cells that survive the crisis phase grow after an ill-defined culture adaptation event. SV40 T antigen circumvents the first crisis phase," and stromal cells establish with a IO-fold higher frequency then primary cells (C.M.S., unpublished observation, February 1993). Thus, it is reasonable to assume that analyzed in both the murine and human system,' although a systematic comparison of the ability of these lines to support repopulating stem cells has not been performed until now. We used the competitive repopulation assay to assess stem cell activity in stromal cell cultures. This assay is the most stringent way of detecting and quantitating stem cells.". '8 Because the cultured stem cells compete with freshly explanted marrow, qualitative and quantitative differences in repopulation capacity are revealed. This, together with repeated measurement of repopulation, revealed that the stromal cell lines differed not only in how many but also in what type of stem cells they supported. The inductive microenvironment hypothesiG5 has been m~d i f i e d~* .~~ to state that the transition from primitive to less primitive stem cells is regulated by distinct stromal cell niches that interact with specific subsets of stem cells. Our data lend experimental support to this hypothesis. On the basis of our data, we would predict that niches that support less primitive stem cells are more abundant than those that sustain more primitive stem cells. This interpretation could, at least in part, provide an explanation for the loss of stem cells seen during repeated transplantation.36 Due to the rarity of stromal cell niches that permit stem cell maintenance in the host's microenvironment, most stem cells would not find appropriate microenvironments and therefore would be lost through death andor differentiation. This hypothesis makes a testable prediction that conditioning of the host with selected stromal cell line$' would improve stem cell recovery posttransplantation.
Stem cells maintained on lines CFCO34 and S 17 competed well with freshly explanted marrow and repopulated hosts at similar levels and with similar kinetics as freshly explanted marrow stem cells. Thus, these stromal cell lines provide conditions that maintain primitive stem cells that qualitatively resemble marrow resident stem cells. However, the majority of the stromal cell lines do not provide ideal environments for stem cells. This was particularly surprising For personal use only. on November 11, 2017. by guest www.bloodjournal.org From because day 14 fetal liver is the site of active expansion of the hematopoietic system. Which mechanisms account for the failure of most stromal cell lines to support stem cells is currently addressed in our laboratories. Similarly, whether the stromal cell lines act directly onto stem cells or via indirect mechanism remains to be established definitively.
However, our data indicate that stromal cells or other cells in the inoculum were not sufficient for stem cell maintenance, even when conditioned stromal cell supernatant was present. Perhaps more interestingly, these data suggest that repopulating stem cells need direct contact to the stromal cell line. A requirement for direct contact would explain how stromal cells provide localized niches for stem cells. 38 That stromal cell lines change function over time is not a new idea.30-32 Our previous analysis3' of the ability of the lines S17, 2018, and 2012 to support B lymphocyte and myeloid cell, indicated that the ' 'nontransformed" bone marrow-derived line S17 showed as much intraclonal variability as the SV40-transformed fetal liver-derived lines 2018 and 2012. This finding has been extended to stem cell support, in that subclones derived from these lines showed a comparable number of loss variants (data not shown). The stromal cell line 201 2 proved to be particularly temperamental. Early on, we noted morphologic heterogeneity within this line (data not shown); small slow-growing cells coexisted with larger, rapidly proliferating fibroblastic cells. However, the analysis of retroviral integration sites in the parental line and in its subclones indicate that the line was clonally derived. Morphologic heterogeneity within SV40-transformed, cloned stromal cell lines has been described p r e v i o~s l y ,~~ although the biological basis for this phenomenon remains to be elucidated. The original 2012 line sustained high levels of stem cells in one experiment; however, neither the parental line nor its subclones were able to do so in repeat experiments. The original experiment included control cultures supported by the line S17 (Figs 1 and 2) , which behaved normally. Both lines were seeded with the same source of bone marrow, and both cultures were tested against the same competitor marrow. This suggests that experimental variation is unlikely to account for this finding. Furthermore, there are strong similarities in the repopulation kinetics of stem cells cultured on the parental line in the original experiment and stem cells cultured on subclones 2012-B1 and 2012-S4, respectively. The onset of peripheral donor type repopulation was noticeably delayed, when compared with stem cells derived from freshly explanted marrow or from cells cultured on the lines S17 or CFCO34. This suggests that the 2012 lines support very primitive stem cells. In addition, the discrepancy between the original and the subsequent experiment suggests that the ability of a stromal cell line to support very primitive stem cells is independent and separable from the capacity to support high levels of stem cells.
The identification of stromal cell lines that differ in stem cell support opens avenues to discover the physiologic molecules that regulate stem cells. Our analysis indicates that transcription of none of the cytokines tested was predictive for stem cell support. Clearly, RT-PCR analysis does not address the quantitative protein production of these cytokines or whether different forms (eg, membrane-bound or secreted) of these cytokines are produced. Nevertheless, our data are in agreement with previously published results that many cytokines contribute to the expansion and maturation of immature cells but fall short in the long-term maintenance of marrow repopulating stem c~U S . ' .~~,~' While these studies do not exclude that these cytokines can act on stem cells, it seems likely that yet to be characterized molecules or interactions play a crucial role in the regulation of stem cells.
